A Revolutionary Chemoproteomic Platform

for Drug Discovery

Discover Novel Therapeutic Targets and Quality Leads

Accelerate Therapeutic Innovation to Improve Human Life

OUR TARGETS

TarGead Sciences is a biomedical company based on novel and high-throughput chemical proteomic platform. TarGead Sciences is focused on accelerating industrial and academic therapeutic innovation to improve human life. We are committed to become the industrial leader in the new era of drug and target discovery.

TARGET

AND LEAD DISCOVERY

Lead and Target Discovery

Lead and Target Licensing

R&D Partnership

STRATEGIC

PARTNERSHIP

Customized Probe Design

Probe Synthesis

Target Validation

TEAM FOUNDERS MANAGEMENT

Chao Zhang

Scientific Founder/Chair of Adviser

VIEW MORE

Alex J. Zhang

CEO

VIEW MORE

Ping Cao, Ph.D.

Vice President of Research

VIEW MORE

Irene Yuan

Director of Finance and Administration

VIEW MORE

Alex J. Zhang

CEO

VIEW MORE

Ping Cao, Ph.D.

Vice President of Research

VIEW MORE

Irene Yuan

Director of Finance and Administration

VIEW MORE

CAREERS

Research Scientist – Biology/Assay Development:

TarGead Sciences, Inc. is a newly launched biopharmaceutical company founded by leading scientists from University of South California and Amgen, Inc. TarGead Sciences employs a proprietary chemoproteomic platform to discover novel therapeutics for the treatment of diverse diseases such as cancer, metabolic disorders and osteoporosis.... VIEW MORE

LOCATION

Burlingame, North America

1633 Old Bayshore Hwy, Suite 280, Burlingame, CA 94010

Shanghai, China

Zhangjiang High Technology Park

NEWS

INVESTORS

CONTACT US
SUBMIT

Corporate Information

Phone:+1(650)504-5586

Email: info@targeadsciences.com